- $221.21m
- $154.31m
- $408.52m
- 38
- 64
- 83
- 65
Annual cashflow statement for Nevro, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -83.1 | -131 | 3 | -92.2 | -113 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 68.7 | 68.7 | 64.4 | 66 | 68.5 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 10.8 | 15.8 | -48.9 | -39.7 | 14.6 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 1.19 | -41.9 | 24.7 | -58.8 | -19.4 |
| Capital Expenditures | -6.03 | -12.3 | -7.54 | -8.59 | -9.79 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -364 | 214 | 71.8 | 1.39 | 24.4 |
| Acquisition of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -370 | 202 | 64.3 | -7.2 | 14.6 |
| Financing Cash Flow Items | -14.7 | -8.06 | -8.85 | -10.6 | -7.75 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 347 | -169 | -2.46 | 49.5 | -4.21 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -21.1 | -9.89 | 85.7 | -16.2 | -9.77 |